In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

Pfizer topped estimates and hiked its full year guidance. Cancer drugs brought in $854 million to Pfizer’s revenue table, ...

The promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients. “The goal is to ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

Fred Hutch Cancer Center brought together a host of experts on November 2 to share tips, tools, resources and strategies for ...

When John noticed blood in his urine, he consulted his doctor and was quickly referred to a urologist. (John is a composite character, based on the experiences of real-life patients.) John was ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...

November is National Bladder Health Awareness Month. According to the American Urological Association, millions of Americans ...

The promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.